Search by Drug Name or NDC

    NDC 25021-0233-20 oxaliplatin 5 mg/mL Details

    oxaliplatin 5 mg/mL

    oxaliplatin is a INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Sagent Pharmaceuticals. The primary component is OXALIPLATIN.

    Product Information

    NDC 25021-0233
    Product ID 25021-233_ea36fe0f-fd6b-470b-a4b6-e1cc7a996157
    Associated GPIs 21100028002025 21100028002030
    GCN Sequence Number 059162
    GCN Sequence Number Description oxaliplatin VIAL 50 MG/10ML INTRAVEN
    HIC3 V1A
    HIC3 Description ANTINEOPLASTIC - ALKYLATING AGENTS
    GCN 24699
    HICL Sequence Number 016687
    HICL Sequence Number Description OXALIPLATIN
    Brand/Generic Generic
    Proprietary Name oxaliplatin
    Proprietary Name Suffix n/a
    Non-Proprietary Name oxaliplatin
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, SOLUTION
    Route INTRAVENOUS
    Active Ingredient Strength 5
    Active Ingredient Units mg/mL
    Substance Name OXALIPLATIN
    Labeler Name Sagent Pharmaceuticals
    Pharmaceutical Class Platinum-based Drug [EPC], Platinum-containing Compounds [EXT]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA203869
    Listing Certified Through 2024-12-31

    Package

    NDC 25021-0233-20 (25021023320)

    NDC Package Code 25021-233-20
    Billing NDC 25021023320
    Package 1 VIAL in 1 CARTON (25021-233-20) / 20 mL in 1 VIAL
    Marketing Start Date 2014-09-15
    NDC Exclude Flag N
    Pricing Information N/A